- Spot gold has just surpassed the $4,410.00/ounce mark, now quoted at $4,407.53/ounce, up 0.91% for the day; the main COMEX gold futures contract is now quoted at $4,472.30/ounce, up 0.70% for the day.
- BRIEF-Hydro One Q2 EPS CAD 0.62
- Grasim Q1FY27 adjusted PAT climbs 49% YoY to ₹2,153 crore; revenue rises 21% to ₹48,716 crore
- Hydro One 2Q EPS C$0.62 >H.T
- Hydro One declares quarterly dividend of $0.35 per share
- Jumia raises US$25 million in equity investment from World Bank’s IFC at US$5.52 per ADS
- Trimble Q2 FY26 GAAP net loss widens to $471.7 million; revenue rises 11% to $972 million
- SUPER MICRO COMPUTER INC. <SMCI.O>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $33.00 FROM $28.00
- BRIEF-Trimble Q2 Revenue USD 972 Million Vs. IBES Estimate USD 951.9 Million
- TARGET CORP. <TGT.N>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $124.00 FROM $110.00
- HAEMONETICS CORPORATION <HAE.N>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $100.00 FROM $93.00
- LY Corp 1H FY26 net loss narrows 9.2% to RM 13.3 million; revenue falls 23.3% to RM 78.41 million
- Martin Marietta prices USD 5.5 billion senior notes offering
- LB PHARMACEUTICALS INC <LBRX.O>: BMO RAISES TARGET PRICE TO $54 FROM $46
- Trimble Sees FY Rev $3.9B-$3.95B >TRMB
- Trimble 2Q Loss/Shr $2.02 >TRMB
- Trimble 2Q Adj EPS 86c >TRMB
- Trimble Sees FY Adj EPS $3.60-Adj EPS $3.70 >TRMB
- Trimble Sees 3Q Rev $953M-$978M >TRMB
- Trimble Sees FY Loss/Shr 7c-Loss 12c >TRMB
- Trimble Sees 3Q EPS 39c-EPS 44c >TRMB
- Trimble 2Q Rev $972M >TRMB
- Trimble Sees 3Q Adj EPS 83c-Adj EPS 88c >TRMB
- A belated slap in the face is still a slap; A100 provides a perfect logic for Neocloud
- Cardone Capital CEO Compares Bitcoin to ‘Portable Digital Real Estate’
- XRP Whale Wallets Rise Even as Price Falls: On-Chain Data Shows Accumulation
- 13-Year-Old Bitcoin Whale Transfers $5.4M in BTC, Sparking Market Speculation
- Ripple Ex-CTO Says Cheating Turns Bitcoin Miners’ ASICs Into Space Heaters
- Kontoor Brands Sees 2026 Adj EPS $5.25-Adj EPS $5.35 >KTB
- Pharvaris Q2 2026 loss widens as company cites higher clinical and commercial buildout costs
- Food Empire 1H FY26 net profit rises 12.2% to US$35.35 million; revenue climbs 15% to US$315.07 million
- Food Empire buys remaining 49.5% of Tea House for USD 240,000
- AFFIRM HOLDINGS, INC. : BMO RAISES TARGET PRICE TO $86 FROM $78
- Stock Markets Face a Lose-Lose on Inflation From -2-
- CARGOJET INC <CJT.TO>: BMO RAISES TARGET PRICE TO C$90 FROM C$85
- Kontoor Brands Q2 FY26 revenue rises 19% to $584 million; diluted EPS falls to $1.03
- K+S sets release of half-year, Q2 consolidated financial report
- Pharvaris Q2 FY26 loss narrows to €47.8 million; R&D expenses rise to €35 million
- Protalix swings to Q2 profit of USD 3.8 million; revenue from selling goods rises 28.5% to USD 19.8 million
- SUMMIT MIDSTREAM CORP <SMC.N>: TD COWEN RAISES TARGET PRICE TO $43 FROM $39
- BRIEF-Kontoor Brands Q2 Gross Margin 56.2%
- BRIEF-Protalix BioTherapeutics Q2 Pretax Profit USD 4.86 Million
- Kontoor Brands 2Q Rev $584.3M >KTB
- Kontoor Brands names Joseph Alkire president, retains CFO role
- AIR CANADA : BMO RAISES TARGET PRICE TO C$37 FROM C$30
- Kontoor Brands 2Q EPS $1.17 >KTB
- Kontoor Brands Reports 2026 Second Quarter Results And Raises Full Year Outlook; Expects To Enter Into A $400 Million Accelerated Share Repurchase Agreement >KTB
- CALUMET, INC. <CLMT.O>: TD COWEN RAISES TARGET PRICE TO $40 FROM $34
- Amundi lifts LEG Immobilien voting stake to 3.74% from 2.99%
- Brinker International Sees FY27 Rev $6.15B-$6.27B >EAT
- Brinker International Sees FY27 Adj EPS $12.60-Adj EPS $13.40 >EAT
- Jumia says first-half 2026 operating loss narrows on usage growth, higher monetization, cost discipline
- Jumia H1 FY26 operating loss narrows to USD 26.25 million; revenue rises 25.2% to USD 102.56 million
- Brinker International 4Q Maggiano's Comparable Restaurant Sales Fell 2.5% >EAT
- Brinker International 4Q Adj EPS $3.07 >EAT
- Dezign Format FY26 1H net profit drops 66.7% to S$0.49 million; revenue falls 10.5% to S$14.99 million
- Brinker Q4 FY26 net income rises 22.52% to $131.1 million; total revenues climb 5.05% to $1.54 billion
- BRIEF-Brinker Q4 Adjusted EPS USD 3.07 Vs. IBES Estimate USD 3.09
- Brinker International: 4Q Chili's Comparable Restaurant Sales Rose 5.6% >EAT
- IDEX CORPORATION <IEX.N>: MIZUHO RAISES TO OUTPERFORM FROM NEUTRAL; RAISES TARGET PRICE TO $280 FROM $210
- Brinker International: 4Q Completes Five Consecutive Years of Chili's Same-Store Sales Growth >EAT
- Brinker International 4Q Net $131.1M >EAT
- Major Canadian Economic Indicators Expected This Week
- Brinker International 4Q Rev $1.54B >EAT
- Brinker International 4Q EPS $2.99 >EAT
- New stock categories added to the market selection pop-up in the elite trade section
- APOGEE THERAPEUTICS, INC. : BTIG CUTS TO NEUTRAL FROM BUY
- Sing Holdings 1H FY26 profit drops 95.8% to SGD 172,000; revenue falls 46% to SGD 4.32 million
- Luke Dashjr removed from Bitcoin BIP process after BIP-110 fails
- Indian inflation accelerates to 4.45% in July, slightly below expectations
- MURPHY OIL CORP <MUR.N>: JP MORGAN RAISES TARGET PRICE TO $43 FROM $42
- Riskified Q2 FY26 net loss narrows to $9.11 million; revenue climbs 22% to $98.69 million
- CANADIAN NATURAL RESOURCES LTD <CNQ.TO>: JP MORGAN RAISES TARGET PRICE TO C$75 FROM C$67
- LUMENTUM HOLDINGS INC. <LITE.O>: MIZUHO RAISES TARGET PRICE TO $1140 FROM $1100
- CARDINAL INFRASTRUCTURE GROUP INC <CDNL.O>: STIFEL CUTS TARGET PRICE TO $52 FROM $63
- Plan Optik to release Q2 group half-year financial report
- COREWEAVE, INC. <CRWV.O>: MIZUHO RAISES TARGET PRICE TO $115 FROM $100
- ARAMARK : STIFEL RAISES TARGET PRICE TO $70 FROM $54
- CAVA GROUP, INC. <CAVA.N>: MIZUHO CUTS TARGET PRICE TO $70 FROM $85
- DELEK US HOLDINGS INC <DK.N>: JP MORGAN RAISES TARGET PRICE TO $70 FROM $62
- Spot trend-following bot now supports rTokens
- SUMMIT THERAPEUTICS INC. <SMMT.O>: LEERINK PARTNERS RAISES TO MARKET PERFORM FROM UNDERPERFORM; RAISES TARGET PRICE TO $13 FROM $12
- CARDINAL HEALTH, INC. <CAH.N>: MIZUHO RAISES TARGET PRICE TO $250 FROM $240
- AXSOME THERAPEUTICS, INC. : MIZUHO RAISES TARGET PRICE TO $316 FROM $306
- Tech Earnings Buoy Stock Futures -- WSJ
- Applied Aerospace & Defense Q2 FY26 net loss widens to $154 million; revenue rises 47.4% to $167.3 million
- Carolina Rush shifts US$27 million Brewer mine purchase price to 10 annual installments after permits
- HLS Therapeutics 2Q Loss $1.02M >HLS.T
- HLS Therapeutics 2Q Rev $14.7M >HLS.T
- Hochtief Benefits From Exposure to Data Centers, Tech -- Market Talk
- HLS Therapeutics 2Q Loss/Shr 3c >HLS.T
- Mobile-Health Network Solutions agrees to buy 19% stake in Singapore’s Jurong Day & Night Clinic for US$ 256,500 in shares
- Bio-Techne declares USD 0.08 quarterly dividend
- Relevant Gold begins 5,000-meter drill program at Lewiston project in Wyoming
- Ituran Q2 FY26 net income rises 29% to $17.3 million; revenue climbs 21% to $104.8 million
- BRIEF-Bio-Techne Q4 Adjusted EPS USD 0.52 Vs. IBES Estimate USD 0.52
- Applied Aerosp & Def 2Q Loss/Shr $1.04 >AADX
- Applied Aerosp & Def 2Q Loss $154M >AADX
- BRIEF-Liquidia Q2 EPS USD 0.74 Vs. IBES Estimate USD 0.74
- Soon Lian HY26 profit rises 162.41% to S$ 6.43 million; revenue increases 37.3% to S$ 57.4 million
